Ferrosa Therapeutics AG ("FERROSA"), a Swiss biotechnology company developing a first-in-class bispecific antibody to treat ...

New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...

After receiving dupilumab vs. topical corticosteroid or prednisone for up to 24 months, the risk for alopecia areata ...

Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...

Cambridge researchers have opened a new phase in our understanding of autoimmune diseases by suggesting they may be driven by ...

What causes autoimmune disease? A new study finds that somatic mutations in immune checkpoint genes like PDL1 trigger the ...

New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes on the immune system. It reveals a previously hidden role for somatic ...

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity ...

Small trial shows similar rate of adverse events to placebo ...

A long-term clinical study suggests that intervening before rheumatoid arthritis fully develops may significantly alter its ...